ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
New therapy for Enlarged Prostate
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="broker" data-source="post: 148366" data-attributes="member: 25926"><p>Vince</p><p>This is a bit more recent.</p><p></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">MARLBOROUGH, Mass., Jan. 25, 2019 /<a href="http://www.prnewswire.com/" target="_blank"><span style="color: rgb(62, 177, 200)">PRNewswire</span></a>/ -- Boston Scientific Corporation (NYSE: BSX) today announced that <a href="https://c212.net/c/link/?t=0&l=en&o=2356911-1&h=1342758878&u=https%3A%2F%2Fwww.goldjournal.net%2Farticle%2FS0090-4295(19)30070-6%2Fabstract&a=data" target="_blank"><span style="color: rgb(62, 177, 200)">data</span></a>from a randomized clinical trial demonstrate that Rezūm™ Water Vapor Therapy, a minimally invasive treatment for benign prostatic hyperplasia (BPH), provides durable results and preserves sexual function four years after treatment. The study, published online ahead of print by <em>Urology</em>, found that patients continued to experience significant and sustained improvement in their symptoms and quality of life over this period.</span></span></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">BPH, which affects 110 million men worldwide, is an enlargement of the prostate in which prostate adenoma cells form excess tissue that may cause symptoms, which impact a patient's quality of life, such as a frequent and urgent need to urinate.1,2</span></span></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">The Rezūm System treats the symptoms of BPH by using water vapor to kill prostate adenoma cells, leading to the cell remnants being absorbed by the body. The procedure can be performed in a physician's office without general anesthesia in a single visit and does not require implants to be placed in the body. The Rezūm System is included in The American Urological Association's BPH treatment guidelines and now has four-year follow-up data showing it can reduce the size of the prostate in all areas of enlarged prostate zones. </span></span></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">"This four-year study supports the use of the first-of-its-kind Rezūm System as a minimally invasive alternative for men with moderate-to-severe BPH who do not want to rely on pharmaceutical management of their symptoms," said Kevin McVary, MD, FACS, lead author and co-principal investigator of the Rezūm II Trial. "The data demonstrate that this advanced technology can empower urologists to achieve significant clinical improvements and deliver an impactful, durable response for their patients."</span></span></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">Over the four years, the trial showed a surgical retreatment rate of 4.4 percent and no new adverse events noted between years three and four. The clinical results also highlighted continued preservation of sexual function, including no de novo erectile dysfunction reported at four years.</span></span></p><p><span style="color: rgb(106, 115, 123)"><span style="font-size: 16px">"With this study, we continue to build a strong body of clinical evidence supporting the Rezūm System as the preferred minimally invasive treatment for BPH, providing long-lasting symptom relief, while preserving sexual function," said Dave Pierce, executive vice president and president, MedSurg, Boston Scientific. "More than 35,000 patients have already been successfully treated with the Rezūm System and we have recently worked with major insurance providers to extend coverage of the procedure, providing even more men with access to this transformative technology." </span></span></p></blockquote><p></p>
[QUOTE="broker, post: 148366, member: 25926"] Vince This is a bit more recent. [FONT=SST-Roman][COLOR=rgb(106, 115, 123)][SIZE=16px]MARLBOROUGH, Mass., Jan. 25, 2019 /[URL='http://www.prnewswire.com/'][FONT=SST-Bold][COLOR=rgb(62, 177, 200)]PRNewswire[/COLOR][/FONT][/URL]/ -- Boston Scientific Corporation (NYSE: BSX) today announced that [URL='https://c212.net/c/link/?t=0&l=en&o=2356911-1&h=1342758878&u=https%3A%2F%2Fwww.goldjournal.net%2Farticle%2FS0090-4295(19)30070-6%2Fabstract&a=data'][FONT=SST-Bold][COLOR=rgb(62, 177, 200)]data[/COLOR][/FONT][/URL]from a randomized clinical trial demonstrate that Rezūm™ Water Vapor Therapy, a minimally invasive treatment for benign prostatic hyperplasia (BPH), provides durable results and preserves sexual function four years after treatment. The study, published online ahead of print by [I][FONT=SST-Italic]Urology[/FONT][/I], found that patients continued to experience significant and sustained improvement in their symptoms and quality of life over this period.[/SIZE][/COLOR][/FONT] [FONT=SST-Roman][COLOR=rgb(106, 115, 123)][SIZE=16px]BPH, which affects 110 million men worldwide, is an enlargement of the prostate in which prostate adenoma cells form excess tissue that may cause symptoms, which impact a patient's quality of life, such as a frequent and urgent need to urinate.1,2 The Rezūm System treats the symptoms of BPH by using water vapor to kill prostate adenoma cells, leading to the cell remnants being absorbed by the body. The procedure can be performed in a physician's office without general anesthesia in a single visit and does not require implants to be placed in the body. The Rezūm System is included in The American Urological Association's BPH treatment guidelines and now has four-year follow-up data showing it can reduce the size of the prostate in all areas of enlarged prostate zones. "This four-year study supports the use of the first-of-its-kind Rezūm System as a minimally invasive alternative for men with moderate-to-severe BPH who do not want to rely on pharmaceutical management of their symptoms," said Kevin McVary, MD, FACS, lead author and co-principal investigator of the Rezūm II Trial. "The data demonstrate that this advanced technology can empower urologists to achieve significant clinical improvements and deliver an impactful, durable response for their patients." Over the four years, the trial showed a surgical retreatment rate of 4.4 percent and no new adverse events noted between years three and four. The clinical results also highlighted continued preservation of sexual function, including no de novo erectile dysfunction reported at four years. "With this study, we continue to build a strong body of clinical evidence supporting the Rezūm System as the preferred minimally invasive treatment for BPH, providing long-lasting symptom relief, while preserving sexual function," said Dave Pierce, executive vice president and president, MedSurg, Boston Scientific. "More than 35,000 patients have already been successfully treated with the Rezūm System and we have recently worked with major insurance providers to extend coverage of the procedure, providing even more men with access to this transformative technology." [/SIZE][/COLOR][/FONT] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
New therapy for Enlarged Prostate
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top